FDA Abandons Proposal For Interactive, “Pre-Decisional” IDE

The agency finalized a guidance document on investigational device exemption review decisions, dropping a proposal to establish a new, interactive “pre-decisional” IDE process. Industry had been skeptical that the proposed program would improve efficiency of study reviews, and worries that it would require a lot of FDA resources.

FDA has dropped current plans for establishing a specialized interactive review process for investigational device exemption submissions.

The agency posted a final guidance on FDA decisions for IDE submissions Aug. 18, following up on a...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Regulation

More from Policy & Regulation